Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
175MO Evaluation of an AI-enabled platform for cancer prevention and genetic risk assessment in unaffected individuals: A randomized study
0
Zitationen
8
Autoren
2025
Jahr
Abstract
Artificial intelligence (AI) is increasingly applied in cancer diagnostics and treatment, yet its role in cancer prevention and hereditary risk assessment remains underexplored. We conducted a prospective randomized study of an AI-enabled platform (OncoDefend) to evaluate feasibility, accuracy, and behavioral impact in unaffected individuals in India.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.200 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.051 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.416 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.410 Zit.